Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), a company that develops health indicators based on trace elements and applies them to real-world use, announces the opening of reservations for its proprietary screening test, the 'Metallo Balance Test,' which evaluates risks for cancer and MCI (Mild Cognitive Impairment). The test will be available at Do-Clinic (Chuo Ward, Sapporo City, Hokkaido), a partner medical institution, with reservations now open for August to October 2026.

With the establishment of a continuous testing system at this clinic, access to the 'Metallo Balance Test' in the Sapporo area will be stabilized, contributing as a practical option for local residents' daily health management and pre-disease prevention.

Renatech will continue to work with partner medical institutions nationwide to maintain and expand testing availability, aiming to encourage more people to take interest in their health and reflect on their daily habits and lifestyle choices as part of pre-disease prevention.

What is the Metallo Balance (MB) Test?

The Metallo Balance Test is a risk screening (triage) test that objectively evaluates the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood draw by analyzing the concentration balance of 17 trace elements (metal elements) in the blood.

【Key Features of the Test】

Single 6mL blood draw: Blood is safely collected under proper medical supervision. The test takes only about 15 minutes, minimizing physical burden and ensuring safety.

Site-specific 'Cancer Risk Test': With a single blood draw, cancer risks are evaluated by body site (6 sites for men, 9 for women) and scored on a four-tier scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer

Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of cognitive impairment, including not only Alzheimer's type but also vascular and Lewy body types.

Proven research results and international recognition: Developed through joint research with Kanagawa Prefectural Cancer Center and Chiba Prefectural Cancer Center, supported by a research grant from the Ministry of Economy, Trade and Industry's Go-Tech program. Patented in 9 countries including Japan, with over 100,000 test-takers cumulatively (from April 2019 to March 2026).

Testing Process and Key Pre-Test Instructions

※ Due to the need for document mailing procedures, advance registration is required approximately three weeks before the desired test date (by the deadline, under a full reservation system).

Registration: Please register via the website or by phone. A complete set of test documents will be delivered to your home about one week before your scheduled appointment.

Test Day (Blood Draw): As the clinic operates on a full reservation basis, blood collection will proceed smoothly (takes about 15 minutes). Payment is on a post-payment basis, so no on-site payment is required on the day.

Results Notification: Your invoice (payment slip) will be mailed to your home approximately three weeks after blood draw, and your test results will be mailed approximately five weeks later.

【Key Pre-Test Instructions】

Food and Alcohol: No food after 9 PM the previous day. No alcohol consumption the day before. Hydration: Please drink plenty of water to make blood draw easier.

Medications and Supplements: Over-the-counter medications and supplements should not be taken the day before. Prescription medications should be taken as usual.

Test Fees (Private Pay)

This test is not covered by health insurance and is offered as a private-pay service. You may choose from the following plans according to your needs:

Cancer Risk Test: 19,800 JPY (tax included)

Cognitive Risk Test: 19,800 JPY (tax included)

Cancer and Cognitive Risk Test Package: 24,200 JPY (tax included)

※ Listed prices are standard rates. ※ Payment will be made via 'DSK Postpay,' delivered to your home after blood draw. ※ Some medical institutions may not offer one of the tests.

Eligibility and Important Notes for the Metallo Balance Test

【Age Eligibility】

Cancer Risk Test: Japanese nationals aged 20 to 80

Cognitive Risk Test: Japanese nationals aged 50 to 80

※ This test was developed based on data from Japanese individuals within the above age ranges. While individuals outside these age groups or non-Japanese nationals may still take the test, results will be considered for reference only. Please understand this in advance.

【Individuals Who Cannot Take the Test】

Pregnant individuals or those who have given birth within the last 6 months

Individuals currently undergoing cancer treatment, or who completed treatment less than one year ago

Individuals undergoing dialysis

Individuals with fractures, blood disorders, or immunodeficiency (excluding lipid abnormalities such as high triglycerides)

Individuals feeling unwell (due to lack of sleep, after an all-nighter, immediately after intense exercise, under severe stress, or experiencing symptoms such as cold, asthma, shingles, allergic rash, or allergic rhinitis)

Overview of Partner Medical Institution

Testing Hours: First Sunday of each month (9:00–11:30) / Weekly Wednesdays (10:00–11:00) (excluding holidays and clinic closure days)

Medical Institution Name: Do-Clinic

Address: 3F, Wisteria Minami-1-Jo Building, 291-81 Minami-1-Jo Nishi 14-Chome, Chuo Ward, Sapporo City, 060-0061, Hokkaido 🅿️ Partner parking available 📍MAP

Access: ● Subway: 5-minute walk from Exit 5 of Nishi-Jūhachi-Chōme Station on the Tōzai Line ● Streetcar: 1-minute walk from Nishi-Jūgo-Chōme Tram Stop on the Sapporo Streetcar

Available Tests: Cancer Risk Test, Cognitive Risk Test

▼ Check Available Dates and Make a Reservation

Schedules for August to October, as well as the latest updates for November and beyond, can be viewed and booked anytime via the web reservation system below.

Metallo Balance Test Web Reservation: https://metallo-balance.net/entry/

<Steps to Check Dates and Register>

From the URL above, select 'General Public' (red button)

Select the corresponding region (Hokkaido) from 'Find Test Location'

Select 'Do-Clinic' as the test venue to view the currently available specific test dates. ※ Each testing slot has a limited capacity. Registration will close once full, so please understand in advance.

⚠️ Important Notice Regarding Testing (Please Read Carefully) Please refrain from contacting the medical institution directly: The hospital front desk or phone line cannot accept reservations or inquiries for this test. All questions and reservations regarding the test should be directed to Renatech.

For more details and registration:

Metallo Balance Test Information Site (for full test details): https://www.mbkensa.com/

Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Version of Metallo Balance Test Brochure

d182526-19-92c4ae905b87afeafabb222903530c63.pdf

🏥 Partner medical institutions nationwide are also being recruited! For information on introducing the Metallo Balance Test, please visit:

Metallo-Balance Original Character: Metalona-chan

Renatech Inc. is an innovation company developing proprietary technologies in the medical and health fields, as well as environmental fields, aiming for early risk assessment of diseases such as cancer. It has been recognized as one of the '300 Outstanding SMEs and Small-Scale Enterprises' by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency for its innovative technological development and service provision.

FACT BOX

  • Source: PR TIMES
  • Category: Partnership
  • Organizations: Do-Clinic